Sebold Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$326K Sell
1,183
-4
-0.3% -$1.09K 0.2% 57
2025
Q1
$315K Hold
1,187
0.21% 53
2024
Q4
$276K Hold
1,187
0.18% 58
2024
Q3
$262K Hold
1,187
0.17% 59
2024
Q2
$233K Sell
1,187
-26
-2% -$5.37K 0.16% 66
2024
Q1
$261K Buy
1,213
+26
+2% +$5.46K 0.18% 63
2023
Q4
$250K Sell
1,187
-113
-9% -$24.1K 0.18% 61
2023
Q3
$260K Sell
1,300
-231
-15% -$45.9K 0.21% 58
2023
Q2
$284K Hold
1,531
0.23% 58
2023
Q1
$293K Hold
1,531
0.23% 53
2022
Q4
$257K Buy
+1,531
New +$266K 0.21% 58

Other funds holding CME

Sebold Capital Management's CME Position: Q2 2025 in Review

Sebold Capital Management reduced its CME Group (CME) stake by 0.34% in Q2 2025, selling an estimated $1.09K and leaving 1,183 shares worth $326K. The position accounts for 0.2% of the portfolio, ranked #57.

Sebold Capital Management first reported a position in CME in Q4 2022 and has held it in 11 quarters since. 1,661 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • Sebold Capital Management held 1,183 shares of CME Group worth $326K as of Q2 2025.
  • Sebold Capital Management sold 4 CME Group shares in Q2 2025, an estimated $1.09K.
  • CME Group made up 0.2% of Sebold Capital Management's portfolio in Q2 2025, its #57 holding.
  • Sebold Capital Management first reported a position in CME Group in Q4 2022 and has held it in 11 quarters since.
  • 1,661 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Sebold Capital Management's 13F filing for Q2 2025, filed 5 Aug 2025.